supp.ai
Discover Supplement-Drug Interactions
Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago
Research Papers that Mention the Interaction
“BACKGROUND The addition of Rituximab to standard chemotherapy ( C ) has been reported to improve the end of treatment outcome in non-Hodgkin lymphoma (NHL) patients.”
Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: a meta-analysis.
Help us improve supp.ai, we'd love to hear your feedback: Submit Feedback